Price movement over the last 24 hours
American Well Corp vs Oklo Inc — how do they compare? American Well Corp trades at $9.61 (market cap $165.58M), while Oklo Inc trades at $48.11 (market cap $8.50B). The key difference: Oklo Inc is far larger — about 51.3× American Well Corp's market cap, and American Well Corp is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| AMWL | OKLO | |
|---|---|---|
Market Cap | $165.58M | $8.50B |
Sector | Health | Technology |
52-Week High | $9.91 | $174.14 |
52-Week Low | $3.78 | $45.58 |
Enterprise Value | -$9.66M | $6.29B |
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
OKLO trades at $48.85, down 0.85% on the day, reflecting ongoing volatility as the stock remains 70% below its 52-week high. Technical indicators show a bearish trend with support at $45, while fundamentals reveal significant losses with a net income of -$105.66M in 2025. Recent news highlights progress with DOE safety approvals for its Groves reactor, but investor sentiment is mixed amid substantial cash burn and equity dilution from financing activities.
The outlook hinges on successful reactor deployment and commercialization, with analyst consensus pointing to 96% upside potential. Key risks include execution delays, regulatory hurdles, and persistent negative cash flow from operations. Long-term growth depends on converting nuclear technology advancements into revenue, making it a high-risk, high-reward opportunity for speculative investors.
Trailing returns across standard periods
Latest headlines on both assets
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →